| Breakdown | TTM | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.98M | 56.32M | 25.43M | 16.27M | 17.05M | 15.56M |
| Gross Profit | 23.86M | 34.46M | 16.07M | 10.28M | 11.41M | 2.63M |
| EBITDA | 13.38M | 15.51M | 4.92M | 1.33M | 3.31M | 1.58M |
| Net Income | 9.96M | 14.05M | 3.14M | 464.00K | 1.47M | 60.00K |
Balance Sheet | ||||||
| Total Assets | 55.02M | 49.79M | 25.27M | 18.09M | 16.44M | 14.61M |
| Cash, Cash Equivalents and Short-Term Investments | 10.51M | 14.49M | 7.21M | 2.61M | 4.01M | 2.91M |
| Total Debt | 6.18M | 3.69M | 3.02M | 2.31M | 1.82M | 2.16M |
| Total Liabilities | 16.41M | 14.42M | 10.45M | 6.54M | 5.40M | 5.25M |
| Stockholders Equity | 38.61M | 35.38M | 14.81M | 11.54M | 11.04M | 9.36M |
Cash Flow | ||||||
| Free Cash Flow | 6.70M | 8.06M | 4.76M | -581.00K | 2.04M | 1.72M |
| Operating Cash Flow | 15.13M | 13.84M | 6.33M | 950.00K | 2.29M | 2.13M |
| Investing Cash Flow | -11.13M | -5.62M | -1.49M | -1.52M | -250.00K | -392.00K |
| Financing Cash Flow | -610.00K | -903.00K | -228.00K | -840.00K | -964.00K | -704.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £53.10M | 10.27 | 17.36% | 4.20% | 5.46% | 12.34% | |
75 Outperform | £439.89M | 27.44 | 26.93% | ― | 121.45% | 345.83% | |
67 Neutral | £242.50M | 25.56 | 3.10% | 2.19% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | £42.68M | -17.38 | 2.30% | 2.02% | 20.83% | ― | |
54 Neutral | £206.60M | -4.02 | -31.21% | ― | -16.33% | -448.12% | |
52 Neutral | £41.02M | 5.88 | 2.29% | 3.67% | -21.33% | -11.35% |